Latest News - National Psoriasis Foundation

Friday, August 25, 2017 | PracticalDermatology.com, National Psoriasis Foundation

National Psoriasis Foundation Honors Research Award Recipients at Biennial Research Symposium

The National Psoriasis Foundation (NPF) recognized two distinguished research professionals for their unique impact on psoriatic disease research during the 2017 NPF Research Symposium. The NPF Med…

Read the full story

Friday, December 30, 2016 | PracticalDermatology.com, Research and Publications, National Psoriasis Foundation

National Psoriasis Foundation Awards 2016 Grants and Fellowships

The National Psoriasis Foundation (NPF) awarded more than $1.9 million in research funding in 2016, including 23 new projects from around the world. Established and emerging scientists recei…

Read the full story

Thursday, November 10, 2016 | Healthcare Trends, PracticalDermatology.com, National Psoriasis Foundation

NPF Offers Open Enrollment Insurance Advice Via New Patient Navigation Center

The National Psoriasis Foundation (NPF) Patient Navigation Center aims to help patients learn more about psoriatic disease, how to manage their condition and get answers to specific insurance and acce…

Read the full story

Tuesday, October 18, 2016 | FDA Approval/Clearance, PracticalDermatology.com, Product Launches and Updates, National Psoriasis Foundation, Pfizer

Biosim Update: Pfizer to Begin Shipping INFLECTRA in Late November 2016

Pfizer Inc. will begin shipment of INFLECTRA (infliximab-dyyb) for injection, a biosimilar of REMICADE1 (infliximab) to wholesalers in the United States in late November 2016. INFLECTRA will be the…

Read the full story

Thursday, September 15, 2016 | Personnel/Company News, PracticalDermatology.com, National Psoriasis Foundation

Save the Date: Sept 28th Marks First Ever PsA Awareness Day

September 28th marks the first-ever Psoriatic Arthritis (PsA) Awareness Day. Launched by Celgene Corporation and the National Psoriasis Foundation (NPF), PsA Awareness Day is dedicated to education…

Read the full story

Wednesday, June 29, 2016 | PracticalDermatology.com, Research and Publications, National Psoriasis Foundation, Novartis

Global Psoriasis Survey: 85% of US Respondents Faced Social Stigma Because of Psoriasis

Novartis released new results from its Clear About Psoriasis Survey, the largest global survey to date of people with moderate-to-severe psoriasis. Findings reveal 85 percent of US respondents have su…

Read the full story

Wednesday, June 29, 2016 | Healthcare Trends, PracticalDermatology.com, Research and Publications, American Society for Dermatologic Surgery, National Psoriasis Foundation

Laser Procedures Seem Generally OK for Psoriasis Patients: Analysis

Patients with psoriasis who undergo laser procedures do not appear to be at risk for koebnerization, according to research published this spring in Dermatologic Surgery and recently reported by t…

Read the full story

Tuesday, May 03, 2016 | PracticalDermatology.com, Product Launches and Updates, National Psoriasis Foundation

Lilly’s Taltz Now Available for Psoriasis

Eli Lilly and Company's Taltz (ixekizumab) injection 80 mg/mL for the treatment of moderate-to-severe plaque psoriasis is now available by prescription order through a contracted network of specia…

Read the full story

Monday, May 02, 2016 | PracticalDermatology.com, National Psoriasis Foundation

Largest Independent US Psoriasis Registry to Track Safety of Ixekizumab Biologic Treatment

The Corrona Psoriasis Registry will track the drug safety reporting for ixekizumab, Eli Lilly and Company's biologic medication that was recently approved for the treatment of moderate-to-severe p…

Read the full story

Tuesday, April 05, 2016 | PracticalDermatology.com, Product Launches and Updates, National Psoriasis Foundation

FDA Approves Inflectra, a Biosimilar to Remicade

And then there were two ... The U.S. Food and Drug Administration approved the biosimilar Inflectra (infliximab-dyyb) for multiple indications. Inflectra is biosimilar to Janssen Biotech, Inc.&rsqu…

Read the full story

Monday, March 28, 2016 | PracticalDermatology.com, National Psoriasis Foundation

More Than 1,000 Patients Join Corrona Psoriasis Registry

The Corrona Psoriasis Registry, a joint collaboration between the National Psoriasis Foundation (NPF) and Corrona, LLC, now includes more than 1,000 patients from 100 sites. Dermatologists assess r…

Read the full story

Friday, March 04, 2016 | PracticalDermatology.com, National Psoriasis Foundation

Medical Professionals, Practical Dermatology® Board Members, Recognized for Outstanding Work in Psoriatic Disease Field

Nominated by patients and colleagues, recipients of the first annual National Psoriasis Foundation Medical Professionals Awards exemplify the outstanding work being done in the psoriatic dis…

Read the full story

Tuesday, July 28, 2015 | PracticalDermatology.com, National Psoriasis Foundation

National Psoriasis Foundation Launches Patient-centered Research Platform

Patients with psoriasis and psoriatic arthritis can contribute directly to the future of research into these chronic, systemic autoimmune diseases through the National Psoriasis Foundation’s pat…

Read the full story

Tuesday, June 23, 2015 | PracticalDermatology.com, National Psoriasis Foundation

National Psoriasis Foundation Awards Half a Million Dollars in Fellowships

Eleven early-career physicians each received a one-year, $50,000 National Psoriasis Foundation Medical Dermatology Fellowship to study psoriasis and psoriatic arthritis. These fellowships will help…

Read the full story